Shopping Cart
Remove All
Your shopping cart is currently empty
CST626 is a PROTAC degrader targeting XIAP, cIAP1, and cIAP2.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $1,099 | - | In Stock |
| Description | CST626 is a PROTAC degrader targeting XIAP, cIAP1, and cIAP2. |
| In vitro | CST626 treated MM.1S cells with DC50,16h values of 2.4 nM (cIAP1), 6.2 nM (cIAP2), and 0.7 nM (XIAP). The IC50 value of CST626 in MOLM13 and SUDHL6 cells was 2.1 nM and 1.6 nM, respectively. CST626 (0-10 μM; 96 h) significantly inhibited the activity of cancer cells. [1] |
| Synonyms | CS T626 |
| Molecular Weight | 1103.42 |
| Formula | C61H82N8O9S |
| Cas No. | 3033993-13-1 |
| Smiles | CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCOC4=CC(=CC=C4)O[C@H]5C[C@H](N(C5)C(=O)[C@H](C6CCCCC6)NC(=O)[C@H](C)NC)C(=O)N[C@@H]7CCCC8=CC=CC=C78)O |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (72.5 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (2.99 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.